321 related articles for article (PubMed ID: 21330350)
1. IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17.
Moens E; Brouwer M; Dimova T; Goldman M; Willems F; Vermijlen D
J Leukoc Biol; 2011 May; 89(5):743-52. PubMed ID: 21330350
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Mattarollo SR; Kenna T; Nieda M; Nicol AJ
Cancer Immunol Immunother; 2007 Aug; 56(8):1285-97. PubMed ID: 17265022
[TBL] [Abstract][Full Text] [Related]
3. Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.
Cabillic F; Toutirais O; Lavoué V; de La Pintière CT; Daniel P; Rioux-Leclerc N; Turlin B; Mönkkönen H; Mönkkönen J; Boudjema K; Catros V; Bouet-Toussaint F
Cancer Immunol Immunother; 2010 Nov; 59(11):1611-9. PubMed ID: 20582413
[TBL] [Abstract][Full Text] [Related]
4. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
[TBL] [Abstract][Full Text] [Related]
5. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.
Haas JD; González FH; Schmitz S; Chennupati V; Föhse L; Kremmer E; Förster R; Prinz I
Eur J Immunol; 2009 Dec; 39(12):3488-97. PubMed ID: 19830744
[TBL] [Abstract][Full Text] [Related]
6. (E)-4-hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated Vgamma9Vdelta2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived dendritic cells.
Dunne MR; Madrigal-Estebas L; Tobin LM; Doherty DG
Cancer Immunol Immunother; 2010 Jul; 59(7):1109-20. PubMed ID: 20306041
[TBL] [Abstract][Full Text] [Related]
7. Partial and ineffective activation of V gamma 9V delta 2 T cells by Mycobacterium tuberculosis-infected dendritic cells.
Meraviglia S; Caccamo N; Salerno A; Sireci G; Dieli F
J Immunol; 2010 Aug; 185(3):1770-6. PubMed ID: 20592281
[TBL] [Abstract][Full Text] [Related]
8. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
Izumi T; Kondo M; Takahashi T; Fujieda N; Kondo A; Tamura N; Murakawa T; Nakajima J; Matsushita H; Kakimi K
Cytotherapy; 2013 Apr; 15(4):481-91. PubMed ID: 23391461
[TBL] [Abstract][Full Text] [Related]
10. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.
Wu CY; Demeure C; Kiniwa M; Gately M; Delespesse G
J Immunol; 1993 Aug; 151(4):1938-49. PubMed ID: 8102154
[TBL] [Abstract][Full Text] [Related]
11. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.
Nagamine I; Yamaguchi Y; Ohara M; Ikeda T; Okada M
Hiroshima J Med Sci; 2009 Mar; 58(1):37-44. PubMed ID: 19400555
[TBL] [Abstract][Full Text] [Related]
12. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
13. Regulation of acquired immunity by gamma delta T-cell/dendritic-cell interactions.
Shrestha N; Ida JA; Lubinski AS; Pallin M; Kaplan G; Haslett PA
Ann N Y Acad Sci; 2005 Dec; 1062():79-94. PubMed ID: 16461791
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
Poccia F; Gioia C; Martini F; Sacchi A; Piacentini P; Tempestilli M; Agrati C; Amendola A; Abdeddaim A; Vlassi C; Malkovsky M; D'Offizi G
AIDS; 2009 Mar; 23(5):555-65. PubMed ID: 19238075
[TBL] [Abstract][Full Text] [Related]
15. Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells.
von Lilienfeld-Toal M; Sievers E; Bodemüller V; Mihailescu C; Märten A; Gorschlüter M; Schmidt-Wolf IG
Immunol Lett; 2005 Jun; 99(1):103-8. PubMed ID: 15894118
[TBL] [Abstract][Full Text] [Related]
16. Workshop cluster 1+ gammadelta T-cell receptor T cells from calves express high levels of interferon-gamma in response to stimulation with interleukin-12 and -18.
Price SJ; Sopp P; Howard CJ; Hope JC
Immunology; 2007 Jan; 120(1):57-65. PubMed ID: 17034425
[TBL] [Abstract][Full Text] [Related]
17. Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5.
Taguchi T; Aicher WK; Fujihashi K; Yamamoto M; McGhee JR; Bluestone JA; Kiyono H
J Immunol; 1991 Dec; 147(11):3736-44. PubMed ID: 1682383
[TBL] [Abstract][Full Text] [Related]
18. CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells.
Ramsdell F; Seaman MS; Clifford KN; Fanslow WC
J Immunol; 1994 Mar; 152(5):2190-7. PubMed ID: 7510740
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.
Kenna TJ; Davidson SI; Duan R; Bradbury LA; McFarlane J; Smith M; Weedon H; Street S; Thomas R; Thomas GP; Brown MA
Arthritis Rheum; 2012 May; 64(5):1420-9. PubMed ID: 22144400
[TBL] [Abstract][Full Text] [Related]
20. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
